Skip to content
DraconiticResearch
Search Sources API
190,869 studies31 sourcesUpdated 49 min ago
Peer-reviewedCC BY 4.0PLOS One

All-atom molecular dynamics simulation of Cyclophilin A in complex with Sanglifehrin A

  • Zahra Aliabadi1
  • Alireza Mohebbi2
  1. 1Student Research Committee, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
  2. 2Department of Virology, Iran University of Medical Sciences, Tehran, Iran
Open at sourcePDFDOICite

Abstract

Cyclophilin A (CypA), a key peptidyl-prolyl cis/trans isomerase, plays a pivotal role in various biological processes and is a target for therapeutic intervention, particularly in viral and cancer-related diseases. This study explores the structural and dynamic effects of Sanglifehrin A (SangfA), a potent CypA inhibitor, using molecular dynamics (MD) simulation. All-atom MD simulations (100 ns) of apo CypA and its complex with SangfA were performed using GROMACS v2023. In addition to MD analyses, essential dynamics, clustering, secondary structure, and binding free energy were analyzed. SangfA binding induces a dual dynamic response: local rigidification of the active-site β2-β3 loop, residues 100–102 and 108–111 with a coil‑to‑β-strand transition (β-sheet content rises from 28.0% to 32.3%), alongside enhanced mobility in distal loops and a 1.1‑fold expansion of the conformational ensemble. Principal component analysis shows redistribution of motions from a single dominant mode (apo PC1 = 44.2%) to more diffuse fluctuations (holo PC1 = 30.4%), increasing configurational entropy. The ligand forms a dynamic hydrogen‑bond network (1–2 persistent bonds) anchored by Arg55 and hydrophobic contacts with Phe60 and Lys105, while Arg55 remains uninvolved. The computed binding free energy (ΔG = −20.45 ± 3.07 Kcal/mol) accords with picomolar potency. SangfA acts via conformational selection, stabilizing a pre‑existing CypA substate with augmented β-structure and broader dynamics. This entropically driven mechanism challenges static inhibition paradigms. Future efforts should validate the β2-β3 loop transition experimentally and exploit the Lys105 contact to design next‑generation cyclophilin inhibitors.

Related

  1. Acute Myeloid Leukemia(AML) proteins for in silico drug design using pharmacophore modeling, molecular docking and molecular dynamics simulation
    Partho Bosu, Tonmoy Adhikary, Abu Sayed Rafi +3
    PLOS OnePeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationProteomics & metabolomicsPLOS
  2. Design, Synthesis, Evaluation, and Molecular Dynamics Simulation of Tadalafil Derivatives for the Treatment of Erectile Dysfunction
    Wentao Liu, Bin Zhang, Yuping Jia +8
    MoleculesPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefEurope PMCDOAJ
  3. On the physics of chromatin molecular complex: from phase-separation to membrane adsorption
    Andrea Fontana, Andrea M. Chiariello
    Frontiers in Molecular BiosciencesPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMC
  4. Structures of the PI3Kα/KRas complex on lipid bilayers reveal molecular mechanisms of PI3Kα activation
    Hayarpi Torosyan, Michael D. Paul, Brigitte G. Meyer +3
    Molecular CellPeer-reviewedLicence not stated9 citedMolecular biology & gene regulationOpenAlex
  5. Inferring protein-induced spontaneous curvature of lipid bilayers from molecular simulation
    A. Hossein, M. A. Brunet, N. Englander +2
    bioRxivPreprintCC BYFull textBiophysicsbioRxiv

Cite

BibTeXRIS
BibTeX
@article{aliabadi2026allatom,
  title = {{All-atom molecular dynamics simulation of Cyclophilin A in complex with Sanglifehrin A}},
  author = {Zahra Aliabadi and Alireza Mohebbi},
  journal = {PLOS One},
  year = {2026},
  month = sep,
  doi = {10.1371/journal.pone.0358847},
  url = {https://doi.org/10.1371/journal.pone.0358847},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - All-atom molecular dynamics simulation of Cyclophilin A in complex with Sanglifehrin A
AU  - Zahra Aliabadi
AU  - Alireza Mohebbi
PY  - 2026
DA  - 2026/09/22
JO  - PLOS One
DO  - 10.1371/journal.pone.0358847
UR  - https://doi.org/10.1371/journal.pone.0358847
AB  - Cyclophilin A (CypA), a key peptidyl-prolyl cis/trans isomerase, plays a pivotal role in various biological processes and is a target for therapeutic intervention, particularly in viral and cancer-related diseases. This study explores the structural and dynamic effects of Sanglifehrin A (SangfA), a potent CypA inhibitor, using molecular dynamics (MD) simulation. All-atom MD simulations (100 ns) of apo CypA and its complex with SangfA were performed using GROMACS v2023. In addition to MD analyses, essential dynamics, clustering, secondary structure, and binding free energy were analyzed. SangfA binding induces a dual dynamic response: local rigidification of the active-site β2-β3 loop, residues 100–102 and 108–111 with a coil‑to‑β-strand transition (β-sheet content rises from 28.0% to 32.3%), alongside enhanced mobility in distal loops and a 1.1‑fold expansion of the conformational ensemble. Principal component analysis shows redistribution of motions from a single dominant mode (apo PC1 = 44.2%) to more diffuse fluctuations (holo PC1 = 30.4%), increasing configurational entropy. The ligand forms a dynamic hydrogen‑bond network (1–2 persistent bonds) anchored by Arg55 and hydrophobic contacts with Phe60 and Lys105, while Arg55 remains uninvolved. The computed binding free energy (ΔG = −20.45 ± 3.07 Kcal/mol) accords with picomolar potency. SangfA acts via conformational selection, stabilizing a pre‑existing CypA substate with augmented β-structure and broader dynamics. This entropically driven mechanism challenges static inhibition paradigms. Future efforts should validate the β2-β3 loop transition experimentally and exploit the Lys105 contact to design next‑generation cyclophilin inhibitors.
SN  - 1932-6203
ER  -